Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

2 Reasons to Buy AbbVie, and 1 Reason to Sell

TheMotleyFool

0 0

2 Reasons to Buy AbbVie, and 1 Reason to Sell: https://g.foolcdn.com/editorial/images/725397/gettyimages-613345556.jpg

AbbVie (NYSE: ABBV) wowed investors last year when it outperformed the S&P 500 index. Shares of the pharmaceutical company climbed 19%, while the benchmark fell by as much.

Since the start of the year, though, AbbVie shares have lost momentum. Why? The company's blockbuster immunology drug, Humira, is facing competition -- and that means sales are set to fall.

At the same time, AbbVie's full portfolio of other blockbusters and a pipeline of promising candidates give us reason to be positive about the company. So what should investors do? Let's look at two reasons to buy AbbVie right now -- and one reason to sell.

Source Fool.com

Like: 0

ABBV

Share